MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018

from Listen to The Lancet Infectious Diseases · host The Lancet

John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.

Episode metadata supplied by the publisher feed · Published Jan 10, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018

0:00 12:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Infectious Diseases?

This episode is 12 minutes long.

When was this Listen to The Lancet Infectious Diseases episode published?

This episode was published on January 10, 2018.

Can I download this Listen to The Lancet Infectious Diseases episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!